Company Description
The Hanover Insurance Group, Inc., through its subsidiaries, provides various property and casualty insurance products and services in the United States.
The company operates through four segments: Core Commercial, Specialty, Personal Lines, and Other. It offers commercial multiple peril, workers’ compensation, commercial automobile, and other commercial lines coverage; and professional and executive lines, marine, and surety and other, as well as specialty property and casualty comprising Hanover program business, excess and surplus business, Hanover specialty industrial, and specialty general liability business coverage.
The company also provides personal automobile; and homeowners and other personal lines, including residences and personal property, liability claims, personal umbrella, inland marine, fire, personal watercraft, personal cyber, and other miscellaneous coverages.
It markets its products and services through independent agents and brokers. The company was formerly known as Allmerica Financial Corp. and changed its name to The Hanover Insurance Group, Inc. in December 2005.
The Hanover Insurance Group, Inc. was founded in 1852 and is headquartered in Worcester, Massachusetts.
Country | United States |
Founded | 1852 |
IPO Date | Oct 10, 1995 |
Industry | Insurance - Property & Casualty |
Sector | Financials |
Employees | 4,900 |
CEO | John Roche |
Contact Details
Address: 440 Lincoln Street Worcester, Massachusetts 01653 United States | |
Phone | 508 855 1000 |
Website | hanover.com |
Stock Details
Ticker Symbol | THG |
Exchange | NYSE |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000944695 |
CUSIP Number | 410867105 |
ISIN Number | US4108671052 |
Employer ID | 04-3263626 |
SIC Code | 6331 |
Key Executives
Name | Position |
---|---|
John Conner Roche | President, Chief Executive Officer and Director |
Jeffrey Mark Farber | Chief Financial Officer, Executive Vice President and Principal Accounting Officer |
Dennis Francis Kerrigan Jr. | Executive Vice President, Assistant Secretary and Chief Legal Officer |
Bryan James Salvatore | Executive Vice President and President of Specialty |
Lindsay France Greenfield | Senior Vice President and Chief investment Officer |
Oksana Lukasheva | Senior Vice President of Corporate Finance |
Mina S. Rona | President of Technology and Life Sciences |
Willard Ty-Lunn Lee | Executive Vice President, Chief Information and Innovation Officer |
Jennifer F. Luisa | Senior Vice President and Chief Marketing Officer |
Denise Tinger Maureen Lowsley B.A. | Executive Vice President and Chief Human Resources Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 3, 2025 | 8-K | Current Report |
Apr 1, 2025 | 144 | Filing |
Mar 31, 2025 | 144 | Filing |
Mar 28, 2025 | 144 | Filing |
Mar 27, 2025 | 144 | Filing |
Mar 27, 2025 | ARS | Filing |
Mar 27, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Mar 27, 2025 | DEF 14A | Other definitive proxy statements |
Mar 26, 2025 | 144 | Filing |
Mar 3, 2025 | 144 | Filing |